close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Psychedelic/Assisted Therapies

Recent news which mentions Psychedelic/Assisted Therapies

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Orange Photonics: New High-Tech Testing For Psychedelic Products
Tags Benzinga Offerings psilocybin mushrooms
From Benzinga
Small Pharma's Q2 2024 Financial Highlights Ahead Of Cybin Merger For Global DMT Business
Tickers CYBN DMT DMTTF
Tags Markets Benzinga DMT
From Benzinga
Congress Halts Hearing On Psychedelics & Veterans As House Speaker Drama Continues
Tags Legal Management Psychedelics Reform
From Benzinga
New Survey Suggests Psilocybin Eases Psychological Distress From Childhood Trauma
Tags Psychedelic/Assisted Therapies Markets Psychedelics
From Benzinga
EXCLUSIVE: Reason For Hope On Veteran Group Efforts, Comments To FDA & 2023 Expectations
Tags Markets Government Benzinga
From Benzinga
Lucy Scientific's Fiscal Year: Operating Expenses Rise As Accumulated Deficit Hits Over $44M
Tickers LSDI
Tags Benzinga fiscal year results Penny Stocks
From Benzinga
Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More
Tickers ATAI CMPS CYBN DMTTF
Tags ATAI HUGE DMTTF
From Benzinga
U.K.'s Prof. David Nutt Ranked World's Top Psychopharmacologist: More On His Contributions & Advocacy
Tickers AWKNF
Tags Psychedelic Science 2023 Conference Mention of Honor AWKNF
From Benzinga
Dem Presidential Candidate Calls For Universal Healthcare, Including Psychedelics Therapy
Tags mental health News Market News
From Benzinga
Cybin And Small Pharma Shareholders Green Light Acquisition Resolution: Results & Expected Dates
Tickers CYBN DMTTF
Tags DMTTF Short/Acting Psychedelics Contracts
From Benzinga
Pioneering Hope: Inside The Veteran's Organization Advancing Psychedelics Reform Policy
Tags Legal Management Global
From Benzinga
EXCLUSIVE: Understanding Real Estate For Psychedelic Treatments Boosted By Geospatial Mapping
Tickers AAPL IBM
Tags Real Estate Benzinga Cody Shandraw
From Benzinga
EXCLUSIVE: The Need To Enhance Psychedelic Therapy Infrastructure, Data-Driven Solutions
Tags HealingMaps Cody Shandraw Real Estate
From Benzinga
Maine's Portland Leads Drug Policy Reform, Decriminalizing Psychedelic Plants And Fungi
Tags Psychedelics Markets Psychedelic/Assisted Therapies
From Benzinga
Decoding Insurance Reimbursement For Psychedelic-Assisted Therapy With BrainFutures Guide
Tags Psychedelic Therapy Reimbursement Psychedelics Markets
From Benzinga
Atai Life Sciences Completes Phase 1 Clinical Study Of Oral Film DMT Formulation
Tickers ATAI
Tags News Market News Cannabis
From Benzinga
Cybin Completes Dosing In Phase 2 Study Of CYB003 For Major Depressive Disorder Treatment
Tickers CYBN
Tags Benzinga Management major depressive disorder
From Benzinga
Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares
Tickers BNOX CYBN MRK
Tags Financing Benzinga BNOX
From Benzinga
Insider's Look At Psychedelics Industry On Risk Management, Gray Market & Cannabis Industry
Tags AlphaRoot Management News
From Benzinga
GH Research's Psychedelic Drug Candidate For Depression Meets FDA: Clinical Program On Hold
Tickers GHRS
Tags Psychedelics Markets Psychedelic/Assisted Therapies
From Benzinga
Gov Newsom Green Lights Medical Psychedelics If Rescheduled And New Marijuana Testing Rules
Tags Cannabis Testing Benzinga Legal
From Benzinga
Psychedelic Therapy Providers: Risk Management Perspective From A Cannabis Insurance Specialist
Tags Regulations News Market News
From Benzinga
Argentina's Nacho Bottinelli On Psychedelics In Latin America: 'Brazil Opened A Giant Portal To Me'
Tags News Market News Cannabis
From Benzinga
Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More
Tickers ATAI CMPS CYBN DMTTF
Tags DMTTF TheraPsil ATAI
From Benzinga
Psychedelics Reform Update: Massachusetts, Pennsylvania, Maine, California, Michigan, Minnesota, Indiana
Tags Benzinga Rumors Markets
From Benzinga
PharmaTher Is 'One Step Closer To Being A Ketamine Leader' Due To FDA Acceptance
Tickers PHRRF
Tags Markets PHRRF Health Care
From Benzinga
Cybin And Fluence Partner To Support EMBARK Training For Phase 3 CYB003 Trial For Depression
Tickers CYBN
Tags Benzinga Fluence Psychedelic Therapists Training
From Benzinga
Depression Relief: Possible Therapy Boost With DMT & SSRIs, Per Small Pharma Clinical Results
Tickers CYBN DMTTF
Tags Markets DMT Clinical Trial DMTTF
From Benzinga
Defense Dept. Grants $1M To Yale & Transcend Therapeutics To Study PTSD Therapy
Tags Markets Psychedelic/Assisted Therapies Transcend Therapeutics
From Benzinga
Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More
Tickers ATAI CMPS CYBN DMTTF
Tags NKE DRUG Psychedelics
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.